Device Trial Radar · NCT07566624
Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Jul 7, 2026
Primary completion
Jan 1, 2029
Study completion Feb 1, 2029
Sponsor
- Lead sponsor
- Fundación EPICAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 5, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the success rate of transfemoral implantation of the Hydra THV biological aortic valve prosthesis in patients with severe symptomatic aortic stenosis. The device is used in accordance with its Instructions for Use as a CE-marked transcatheter heart valve system. The study will assess procedural success, device performance, and early clinical outcomes following implantation. Patients undergoing transcatheter aortic valve replacement (TAVR) via the transfemoral approach will be followed to evaluate safety and effectiveness outcomes, including short- and mid-term clinical follow-up.
Conditions
- Severe Aortic Valve Stenosis
- Valvular Heart Disease
- Aortic Valve Stenosis
Interventions
Hydra THVDevice
Patients in whom the Hydra THV device is implanted to treat patients with degenerated aortic bioprostheses.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of the success rate of implantationTime frame: 7 days
- Success of the procedureTime frame: 7 days
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Hospital Clínico San Carlos
Aravaca, Spain · Recruiting
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain · Recruiting
Hospital Universitario La Paz
Fuencarral-El Pardo, Spain · Recruiting
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.